{"name": "Intelliject",
 "permalink": "intelliject",
 "crunchbase_url": "http://www.crunchbase.com/company/intelliject",
 "homepage_url": "http://www.intelliject.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2010,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@intelliject.com",
 "phone_number": "804.545.6360",
 "description": "",
 "created_at": "Wed Dec 02 06:43:24 UTC 2009",
 "updated_at": "Fri May 03 16:56:46 UTC 2013",
 "overview": "\u003Cp\u003EIntelliject is a specialty pharmaceutical company dedicated to developing combination drug/device products that empower patients to control and gain freedom from their medical conditions. Each Intelliject product in development combines an established drug, an innovative delivery platform and a supporting dossier intended to show superiority, patient preference and cost effectiveness data.\u003C/p\u003E\n\n\u003Cp\u003EIntelliject applies rigorous selection criteria to identify areas where its patient-centric approach and proprietary technology will offer superior solutions. The company only proceeds to an active development program once it has established that incremental clinical and economic benefit is achievable. Intelliject has a focused pipeline of active programs across a number of therapeutic areas, including small molecules and biologics.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       83],
      "assets/images/resized/0006/8241/68241v3-max-150x150.jpg"],
     [[180,
       100],
      "assets/images/resized/0006/8241/68241v3-max-250x250.jpg"],
     [[180,
       100],
      "assets/images/resized/0006/8241/68241v3-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "T.",
      "last_name": "Spencer Williamson",
      "permalink": "t-spencer-williamson",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/8399/258399v1-max-150x150.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8399/258399v1-max-250x250.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8399/258399v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Chief Commercial Officer ",
    "person":
     {"first_name": "Neil",
      "last_name": "Hughes",
      "permalink": "neil-hughes",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/8411/258411v1-max-150x150.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8411/258411v1-max-250x250.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8411/258411v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Christopher",
      "last_name": "T. Schools",
      "permalink": "christopher-t-schools",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/8405/258405v1-max-150x150.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8405/258405v1-max-250x250.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8405/258405v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Vice President, Industrialization and Quality. ",
    "person":
     {"first_name": "Mark",
      "last_name": "Licata",
      "permalink": "mark-licata",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/8417/258417v1-max-150x150.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8417/258417v1-max-250x250.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8417/258417v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Vice President, Product Development.",
    "person":
     {"first_name": "Evan",
      "last_name": "Edwards",
      "permalink": "evan-edwards",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/8407/258407v1-max-150x150.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8407/258407v1-max-250x250.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8407/258407v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Vice President, Business Development",
    "person":
     {"first_name": "Kristopher",
      "last_name": "D. Ford",
      "permalink": "kristopher-d-ford",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/8403/258403v1-max-150x150.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8403/258403v1-max-250x250.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8403/258403v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Chief Science Officer",
    "person":
     {"first_name": "Eric",
      "last_name": "Edwards",
      "permalink": "eric-edwards",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/8406/258406v1-max-150x150.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8406/258406v1-max-250x250.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8406/258406v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Board Director",
    "person":
     {"first_name": "Wayne",
      "last_name": "Hunter",
      "permalink": "wayne-hunter",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Drug Development and Regulatory Affairs",
    "person":
     {"first_name": "Ron",
      "last_name": "Gunn",
      "permalink": "ron-gunn",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/8408/258408v1-max-150x150.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8408/258408v1-max-250x250.jpg"],
          [[250,
            250],
           "assets/images/resized/0025/8408/258408v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Tim",
      "last_name": "Mayleben",
      "permalink": "tim-mayleben",
      "image":
       {"available_sizes":
         [[[114,
            150],
           "assets/images/resized/0026/7086/267086v1-max-150x150.jpg"],
          [[190,
            250],
           "assets/images/resized/0026/7086/267086v1-max-250x250.jpg"],
          [[200,
            263],
           "assets/images/resized/0026/7086/267086v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$15M",
 "funding_rounds":
  [{"round_code": "debt_round",
    "source_url": "http://www.finsmes.com/2012/05/intelliject-receives-15m-debt-financing-hercules-technology-growth-capital.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Intelliject Receives $15M Debt Financing from Hercules Technology Growth Capital",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 5,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Hercules Technology Growth Capital",
         "permalink": "hercules-technology-growth",
         "image":
          {"available_sizes":
            [[[150,
               51],
              "assets/images/resized/0001/4495/14495v6-max-150x150.png"],
             [[250,
               86],
              "assets/images/resized/0001/4495/14495v6-max-250x250.png"],
             [[416,
               144],
              "assets/images/resized/0001/4495/14495v6-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "111 Virginia St.",
    "address2": "Ste. 405",
    "zip_code": "23219",
    "city": "Richmond",
    "state_code": "VA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0006/8240/68240v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0006/8240/68240v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0006/8240/68240v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}